Orphanet: Simple search
x

Search for a diagnostic test

* (*) mandatory field

15 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation
;

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Diagnosis of susceptibility to 5-fluorouracil toxicity (DPYD and TYMS genes; exons 2-6-10-11-13-14-18-19-22 - IVS14+1)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Diagnosis of susceptibility to 5-fluorouracil toxicity (DPYD gene; 4 hot spot mutations: DPYD*2A, DPYD*13, D949V, HapB3)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Diagnosis of resistance to colchicine (ABCB1 gene - c.3435C>T, c.1199G>A)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Diagnosis of efavirenz toxicity (CYP2B6 gene; CYP2B6*6,*11,*18 genotyping)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Diagnosis of major susceptibility to antidepressant or antipsychotic toxicity or dose selection, Voriconazole toxicity and resistance to Clopidogrel (CYP2C19 gene; CYP2C19*2, *3, *17 genotyping)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Diagnosis of major susceptibility to oral antidiabetic drugs and vitamin K antagonists toxicity or dose selection (CYP2C9 gene; CYP2C9*2, *3 genotyping)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Diagnosis of major susceptibility to antidepressant or antipsychotic toxicity or dose selection, codeine toxicity and resistance to tamoxifene (CYP2D6 gene; CYP2D6*2, *3, *4, *5, *6, *7, *8, *9, *10, *11, *15, *17, *29, *35, *41 genotyping)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Deletion / Duplication analysis
Technique(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Diagnosis of tacrolimus dose selection (CYP3A4 gene; CYP3A4*22 genotyping)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Diagnosis of tacrolimus dose selection (CYP3A5 gene; CYP3A5*3, (*6) genotyping)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Pharmacogenetics analysis of UGT1A1 gene (UGT1A1*28, *36, *37 {A(TA)nTAA} + *6 genotyping)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing, PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Analysis of response to antiviral treatment in hepatitis C (IFNL3 gene; rs8099917 (T>G) + rs12979860 (C>T))
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Diagnosis of statin toxicity (SLCO1B1*1b, *5, *15 genotyping)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Pharmacogenetics analysis of TPMT gene (TPMT*2, *3A, *3B, *3C, *4, exons 5-6-7-10 genotyping)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Analysis of resistance to vitamin K antagonists (VKORC1 gene)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Accreditation
Analysis of vitamin K antagonists toxicity or dose selection (VKORC1 genotyping:-1639G>A + 1173C>T)
Cliniques universitaires Saint-Luc - UCLouvain
Purpose(s) : Pharmacogenetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques